Name | Relative Retention Time | Limit % |
Simvastatin hydroxyacid1 | 0.45 | 0.4 |
Epilovastatin2 and Lovastatin | 0.60 | 1.03 |
Methylene simvastatin4 | 0.80 | 0.4 |
Simvastatin | 1.0 | n/a |
Acetyl simvastatin5 | 2.38 | 0.4 |
Anhydro simvastatin6 | 2.42 | 0.4 |
Simvastatin dimer7 | 3.80 | 0.4 |
Any other individual impurity | | 0.1 |
Total impurities other than lovastatin and epilovastatin | | 1.0 |
1
(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid.
2
(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2R)-2-methylbutanoate.
3
If present, lovastatin and epilovastatin may not be completely resolved by the method. These peaks are integrated together to determine conformance.
4
(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate.
5
(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate.
6
(1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate.
7
(2R,4R)-2-[[(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl]-6-oxotetrahydro-2H-pyran-4-yl (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate.
|
Time (minutes) |
Solution A
(%) |
Solution B
(%) |
Elution |
04.5 | 100 | 0 | isocratic |
4.54.6 | 100®95 | 0®5 | linear gradient |
4.68.0 | 95®25 | 5®75 | linear gradient |
8.011.5 | 25 | 75 | isocratic |
11.511.6 | 25®100 | 75®0 | linear gradient |
11.613 | 100 | 0 | re-equilibration |
Topic/Question | Contact | Expert Committee |
Monograph | Elena Gonikberg, Ph.D.
Senior Scientist 1-301-816-8251 |
(MDGRE05) Monograph Development-Gastrointestinal Renal and Endocrine |
Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |